Caesar Ordonez
Keine laufenden Positionen mehr
Profil
Caesar Ordonez is a Director and Chief Medical Physicist of MIICRO, Inc. He joined MIICRO, Inc. in 2002.
He received a PhD from the Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Caesar Ordonez
| Unternehmen | Position | Ende |
|---|---|---|
Abiant, Inc.
 Abiant, Inc. Medical/Nursing ServicesHealth Services Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL. | Corporate Officer/Principal | - |
MIICRO, Inc.
 MIICRO, Inc. Pharmaceuticals: MajorHealth Technology MIICRO, Inc. develops pharmaceuticals for the central nervous system. It uses neuroimaging technology to research and develop pharmaceuticals for the central nervous system. The company's customers include GlaxoSmithKline, Pfizer, and Eli Lilly. It was founded in 1994 and is located in Chicago, IL | Direktor/Vorstandsmitglied | - |
Ausbildung von Caesar Ordonez
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
MIICRO, Inc.
MIICRO, Inc. Pharmaceuticals: MajorHealth Technology MIICRO, Inc. develops pharmaceuticals for the central nervous system. It uses neuroimaging technology to research and develop pharmaceuticals for the central nervous system. The company's customers include GlaxoSmithKline, Pfizer, and Eli Lilly. It was founded in 1994 and is located in Chicago, IL | Health Technology |
Abiant, Inc.
Abiant, Inc. Medical/Nursing ServicesHealth Services Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL. | Health Services |
